GENE ONLINE|News &
Opinion
Blog

Obesity
Obesity Hope or Hype: Leveraging the Efficacy of Mainstream Weight Loss Pills (First Part)
2024-02-15
Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity
2024-02-07
Semaglutide-Based Medications, Ozempic and Wegovy, Show Lower Suicidal Ideation Risk
2024-01-17
JPM 2024: Pfizer’s Strategic Moves in the Obesity Drug Market and BioNTech’s Oncology Pipeline Expansion
2024-01-10
New Research Links High-Sugar Diets and Obesity to Neurodegenerative Disorders
2023-11-14
Decoding Overweight and Obesity: The Significance of Brain Structure
2023-08-24
Novo Nordisk Delivers Strong H1 Financial Performance, With Acquisition to Expand Weight Loss Market
2023-08-16
Lilly’s Oral GLP-1 Agonist Shows Encouraging Results for Weight Management
2023-06-28
WHO
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
EMA Upholds Recommendation For Withdrawing Marketing Authorization for Amfepramone Obesity Medicines
2022-10-28
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
Reversing Obesity: Cytokine Treatment Makes Obese Mice ‘Sweat Fat’, UPenn Study Finds
2021-08-07
1 2 3
LATEST
One in Four U.S. Adults Turns to AI Tools for Health Care Advice
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
Vitiligo: Causes, Life-Changing Impacts, Treatment Challenges, and Breakthrough New Drugs
2026-04-14
Chris Chen Presents Faraday Future AI Robotics Advancements at Harvard Science Center
2026-04-14
General Lance W. Lord to Receive Space Foundation Lifetime Space Achievement Award for Leadership in Military Space Operations
2026-04-14
Ronald Kopas Reports 11.2 Percent Ownership in Delta Resources Following Private Share Acquisition
2026-04-14
Alcoa Corporation to Redeem $219 Million of 6.125% Notes Due 2028
2026-04-14
Scroll to Top